Severe Skin Rash Associated with Atazanavir
Author(s) -
Andrew Walkty,
D. C. WHARTON SMITH,
Bernie Lopko,
Ken Kasper
Publication year - 2008
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2009/721956
Subject(s) - atazanavir , rash , maculopapular rash , discontinuation , medicine , dermatology , adverse effect , surgery , immunology , antiretroviral therapy , human immunodeficiency virus (hiv) , viral load
Three cases of severe rash associated with the use of atazanavir are described. In all cases, the rash was maculopapular and pruritic. Rash onset occurred eight to 11 days after initiation of therapy, and resolved with atazanavir discontinuation. Clinicians prescribing atazanavir should be aware of this potential adverse effect.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom